ScreenerHero

ORGSOrgenesis Inc.

NAS · US · Healthcare · Biotechnology · orgenesis.com
0.1000USD-66.67%Mkt Cap: 979953 $P/E: —

Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap979.95K $
Enterprise Value18.04M $
Revenue (TTM)1.03M $
Gross Profit-8.47M $
Net Income (TTM)-48.16M $
Revenue/Share0.2460 USD
Last Price0.1000 USD
Fiscal Year EndDec 2024
MR QuarterSep 2024
Employees77
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.05
PEG—
EV/EBITDA-0.75
EV/Revenue17.43
P/S0.31
P/B-0.00
EPS (TTM)-11.44
EPS (Forward)0.61
52W Range
0.004210% of range1.000
52W High1.000 USD
52W Low0.0042 USD
Profitability
Gross Margin-818.55%
Oper. Margin-2196.25%
EBITDA Margin0.00%
Profit Margin-4653.62%
ROE128.44%
ROA-3565.14%
Growth
Revenue Growth215.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.08M $
CapEx (TTM)263.00K $
FCF Margin-524.83%
FCF Yield-554.31%
Net Debt17.09M $
Net Debt/EBITDA-0.71
Balance Sheet
Debt/Equity-0.49
Current Ratio0.03
Quick Ratio0.00
Book Value/Sh-7.2520 USD
Cash/Share0.0210 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 16, 2017
Splits
Last Split1:10
Split DateSep 25, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.80M
Float3.64M
Insiders46.42%
Institutions0.52%
Short Interest
Short Ratio2.4d
Short % Float1.33%
Short % Out.1.18%
Shares Short56.25K
Short (prev mo.)40.51K
Technical
SMA 500.3380 (-70.4%)
SMA 2000.3780 (-73.5%)
Beta3.35
S&P 52W Chg18.16%
Avg Vol (30d)220
Avg Vol (10d)357
Technical Indicators
RSI (14)33.6
MACD-0.0129
MACD Signal0.0056
MACD Hist.-0.0185
BB Upper0.4988 USD
BB Middle0.3585 USD
BB Lower0.2182 USD
BB Width78.26%
ATR (14)0.0792 USD
Vol Ratio (20d)1.16x